Shibeshih Belachew - Publications

Neurology University of Liège, Liège, Wallonie, Belgium 
Multiple Sclerosis

68 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Wolinsky JS, Montalban X, Hauser SL, Giovannoni G, Vermersch P, Bernasconi C, Deol-Bhullar G, Garren H, Chin P, Belachew S, Kappos L. Evaluation of no evidence of progression or active disease (NEPAD) in patients with primary progressive multiple sclerosis in the ORATORIO trial. Annals of Neurology. PMID 30155979 DOI: 10.1002/ana.25313  0.32
2016 Spelman T, Kalincik T, Jokubaitis V, Zhang A, Pellegrini F, Wiendl H, Belachew S, Hyde R, Verheul F, Lugaresi A, Havrdová E, Horáková D, Grammond P, Duquette P, Prat A, et al. Comparative efficacy of first-line natalizumab vs IFN-β or glatiramer acetate in relapsing MS. Neurology. Clinical Practice. 6: 102-115. PMID 27104064 DOI: 10.1212/CPJ.0000000000000227  1
2016 Wiendl H, Butzkueven H, Kappos L, Trojano M, Pellegrini F, Paes D, Zhang A, Belachew S. Epoch Analysis of On-Treatment Disability Progression Events over Time in the Tysabri Observational Program (TOP). Plos One. 11: e0144834. PMID 26771747 DOI: 10.1371/journal.pone.0144834  1
2015 Voloshyna N, Havrdová E, Hutchinson M, Nehrych T, You X, Belachew S, Hotermans C, Paes D. Natalizumab improves ambulation in relapsing-remitting multiple sclerosis: results from the prospective TIMER study and a retrospective analysis of AFFIRM. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 22: 570-7. PMID 25511792 DOI: 10.1111/ene.12618  1
2014 Lublin FD, Cutter G, Giovannoni G, Pace A, Campbell NR, Belachew S. Natalizumab reduces relapse clinical severity and improves relapse recovery in MS. Multiple Sclerosis and Related Disorders. 3: 705-11. PMID 25891549 DOI: 10.1016/j.msard.2014.08.005  1
2014 Plavina T, Subramanyam M, Bloomgren G, Richman S, Pace A, Lee S, Schlain B, Campagnolo D, Belachew S, Ticho B. Anti-JC virus antibody levels in serum or plasma further define risk of natalizumab-associated progressive multifocal leukoencephalopathy. Annals of Neurology. 76: 802-12. PMID 25273271 DOI: 10.1002/ana.24286  1
2014 Butzkueven H, Kappos L, Pellegrini F, Trojano M, Wiendl H, Patel RN, Zhang A, Hotermans C, Belachew S. Efficacy and safety of natalizumab in multiple sclerosis: interim observational programme results. Journal of Neurology, Neurosurgery, and Psychiatry. 85: 1190-7. PMID 24532785 DOI: 10.1136/jnnp-2013-306936  1
2013 De Brabander I, Yperzeele L, Ceuterick-De Groote C, Brouns R, Baker R, Belachew S, Delbecq J, De Keulenaer G, Dethy S, Eyskens F, Fumal A, Hemelsoet D, Hughes D, Jeangette S, Nuytten D, et al. Phenotypical characterization of α-galactosidase A gene mutations identified in a large Fabry disease screening program in stroke in the young. Clinical Neurology and Neurosurgery. 115: 1088-93. PMID 23219219 DOI: 10.1016/j.clineuro.2012.11.003  1
2012 Phan-Ba R, Belachew S, Outteryck O, Moonen G, Sindic C, Vokaer M, Vermersch P. The earlier, the smaller, the better for natalizumab-associated PML: in MRI vigilance veritas? Neurology. 79: 1067-9. PMID 22914844 DOI: 10.1212/WNL.0b013e31826846b4  1
2012 Lommers E, Lecrompe L, Moonen G, Phan-Ba R, Belachew S. [Vitamin D tweets light to genes in multiple sclerosis]. Revue MéDicale De LièGe. 67: 359-65. PMID 22891491  1
2012 Phan-Ba R, Calay P, Grodent P, Delrue G, Lommers E, Delvaux V, Moonen G, Nagels G, Belachew S. A corrected version of the Timed-25 Foot Walk Test with a dynamic start to capture the maximum ambulation speed in multiple sclerosis patients. Neurorehabilitation. 30: 261-6. PMID 22672939 DOI: 10.3233/NRE-2012-0754  1
2012 Phan-Ba R, Calay P, Grodent P, Delrue G, Lommers E, Delvaux V, Moonen G, Belachew S. Motor fatigue measurement by distance-induced slow down of walking speed in multiple sclerosis. Plos One. 7: e34744. PMID 22514661 DOI: 10.1371/journal.pone.0034744  1
2012 Phan-Ba R, Lommers E, Moonen G, Belachew S, Nath A. Immune reconstitution inflammatory syndrome in natalizumab-associated PML. Neurology. 78: 73; author response . PMID 22201114 DOI: 10.1212/01.wnl.0000410335.08123.dc  1
2012 Phan-Ba R, Lommers E, Tshibanda L, Calay P, Dubois B, Moonen G, Clifford D, Belachew S. MRI preclinical detection and asymptomatic course of a progressive multifocal leucoencephalopathy (PML) under natalizumab therapy. Journal of Neurology, Neurosurgery, and Psychiatry. 83: 224-6. PMID 22013244 DOI: 10.1136/jnnp-2011-300511  1
2011 Phan-Ba R, Lambinet N, Louis E, Delvenne P, Tshibanda L, Boverie J, Moonen G, Belachew S. Natalizumab to kill two birds with one stone: a case of celiac disease and multiple sclerosis. Inflammatory Bowel Diseases. 17: E62-3. PMID 21472830 DOI: 10.1002/ibd.21716  1
2011 Phan-Ba R, Pace A, Calay P, Grodent P, Douchamps F, Hyde R, Hotermans C, Delvaux V, Hansen I, Moonen G, Belachew S. Comparison of the timed 25-foot and the 100-meter walk as performance measures in multiple sclerosis. Neurorehabilitation and Neural Repair. 25: 672-9. PMID 21436388 DOI: 10.1177/1545968310397204  1
2011 Phan-Ba R, Bisig B, Deprez M, De Prijck B, Delrue G, Herens C, Moonen G, Belachew S, de Leval L. Primary central nervous system lymphoma in a patient treated with natalizumab. Annals of Neurology. 69: 1060-1; author reply. PMID 21328606 DOI: 10.1002/ana.22296  1
2011 Beukelaers P, Vandenbosch R, Caron N, Nguyen L, Belachew S, Moonen G, Kiyokawa H, Barbacid M, Santamaria D, Malgrange B. Cdk6-dependent regulation of G(1) length controls adult neurogenesis. Stem Cells (Dayton, Ohio). 29: 713-24. PMID 21319271 DOI: 10.1002/stem.616  1
2011 Belachew S, Phan-Ba R, Bartholomé E, Delvaux V, Hansen I, Calay P, Hafsi KE, Moonen G, Tshibanda L, Vokaer M. Natalizumab induces a rapid improvement of disability status and ambulation after failure of previous therapy in relapsing-remitting multiple sclerosis. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 18: 240-5. PMID 20561044 DOI: 10.1111/j.1468-1331.2010.03112.x  1
2010 Brouns R, Thijs V, Eyskens F, Van den Broeck M, Belachew S, Van Broeckhoven C, Redondo P, Hemelsoet D, Fumal A, Jeangette S, Verslegers W, Baker R, Hughes D, De Deyn PP. Belgian Fabry study: prevalence of Fabry disease in a cohort of 1000 young patients with cerebrovascular disease. Stroke; a Journal of Cerebral Circulation. 41: 863-8. PMID 20360539 DOI: 10.1161/STROKEAHA.110.579409  1
2009 Hotermans C, Belachew S, Moonen G, Delwaide J. Severe liver dysfunction in a patient with multiple sclerosis: the guilty party is not always the disease-modifying therapy. Multiple Sclerosis (Houndmills, Basingstoke, England). 15: 1378-9. PMID 19965562 DOI: 10.1177/1352458509345910  1
2009 Jedidi Z, Jedidi H, Moonen G, Belachew S. [Monoclonal antibodies in neurology]. Revue MéDicale De LièGe. 64: 305-9. PMID 19642464  1
2009 Borgs L, Beukelaers P, Vandenbosch R, Nguyen L, Moonen G, Maquet P, Albrecht U, Belachew S, Malgrange B. Period 2 regulates neural stem/progenitor cell proliferation in the adult hippocampus. Bmc Neuroscience. 10: 30. PMID 19327139 DOI: 10.1186/1471-2202-10-30  1
2009 Borgs L, Beukelaers P, Vandenbosch R, Belachew S, Nguyen L, Malgrange B. Cell "circadian" cycle: new role for mammalian core clock genes. Cell Cycle (Georgetown, Tex.). 8: 832-7. PMID 19221497  1
2009 Vandenbosch R, Borgs L, Beukelaers P, Belachew S, Moonen G, Nguyen L, Malgrange B. Adult neurogenesis and the diseased brain. Current Medicinal Chemistry. 16: 652-66. PMID 19199929 DOI: 10.2174/092986709787458371  1
2009 Creppe C, Malinouskaya L, Volvert ML, Gillard M, Close P, Malaise O, Laguesse S, Cornez I, Rahmouni S, Ormenese S, Belachew S, Malgrange B, Chapelle JP, Siebenlist U, Moonen G, et al. Elongator controls the migration and differentiation of cortical neurons through acetylation of alpha-tubulin. Cell. 136: 551-64. PMID 19185337 DOI: 10.1016/j.cell.2008.11.043  1
2008 Pitchot W, Polis M, Belachew S, Ansseau M. [Depression and neuroplasticity]. Revue MéDicale De LièGe. 63: 372-7. PMID 18669207  1
2008 Cuvelier ML, Léonard P, Rikir E, Belachew S. [HIV-related infections of the brain]. Revue MéDicale De LièGe. 63: 342-8. PMID 18669202  1
2008 Cuvelier ML, Léonard P, Rikir E, Belachew S. [When HIV gets into the brain]. Revue MéDicale De LièGe. 63: 338-41. PMID 18669201  1
2008 Scholsem M, Scholtes F, Belachew S, Martin D. Acquired tonsillar herniation and syringomyelia after pleural effusion aspiration: case report. Neurosurgery. 62: E1172-3; discussion . PMID 18580789 DOI: 10.1227/01.neu.0000325884.05871.aa  1
2008 Breuskin I, Bodson M, Thelen N, Thiry M, Nguyen L, Belachew S, Lefebvre PP, Malgrange B. Strategies to regenerate hair cells: identification of progenitors and critical genes. Hearing Research. 236: 1-10. PMID 17920797 DOI: 10.1016/j.heares.2007.08.007  1
2007 Jablonska B, Aguirre A, Vandenbosch R, Belachew S, Berthet C, Kaldis P, Gallo V. Cdk2 is critical for proliferation and self-renewal of neural progenitor cells in the adult subventricular zone. The Journal of Cell Biology. 179: 1231-45. PMID 18086919 DOI: 10.1083/jcb.200702031  1
2007 Vandenbosch R, Borgs L, Beukelaers P, Foidart A, Nguyen L, Moonen G, Berthet C, Kaldis P, Gallo V, Belachew S, Malgrange B. CDK2 is dispensable for adult hippocampal neurogenesis. Cell Cycle (Georgetown, Tex.). 6: 3065-9. PMID 18073538  1
2007 Belachew S, Magis D, Lievens I, Cuvelier ML, Rikir E, Garraux G, Hotermans C, Salmon E, Sadzot B, Cambron L, Maquet P, Poirrier R, Moonen G. [Therapeutic armamentarium in neurology: the birth of a new era]. Revue MéDicale De LièGe. 62: 432-48. PMID 17725219  1
2006 Pirard L, Belachew S, Trotteur G, Van Damme H. [Clinical case of the month. Cerebrovascular accident related to arterial brachiocephalic trunk stenosis]. Revue MéDicale De LièGe. 61: 553-8. PMID 17020227  1
2006 Sohn J, Natale J, Chew LJ, Belachew S, Cheng Y, Aguirre A, Lytle J, Nait-Oumesmar B, Kerninon C, Kanai-Azuma M, Kanai Y, Gallo V. Identification of Sox17 as a transcription factor that regulates oligodendrocyte development. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 9722-35. PMID 16988043 DOI: 10.1523/JNEUROSCI.1716-06.2006  1
2006 Nguyen L, Borgs L, Vandenbosch R, Mangin JM, Beukelaers P, Moonen G, Gallo V, Malgrange B, Belachew S. The Yin and Yang of cell cycle progression and differentiation in the oligodendroglial lineage. Mental Retardation and Developmental Disabilities Research Reviews. 12: 85-96. PMID 16807909 DOI: 10.1002/mrdd.20103  1
2005 Mangin JM, Nguyen L, Gougnard C, Hans G, Rogister B, Belachew S, Moonen G, Legendre P, Rigo JM. Developmental regulation of beta-carboline-induced inhibition of glycine-evoked responses depends on glycine receptor beta subunit expression. Molecular Pharmacology. 67: 1783-96. PMID 15722459 DOI: 10.1124/mol.104.007435  1
2005 Hans G, Wislet-Gendebien S, Lallemend F, Robe P, Rogister B, Belachew S, Nguyen L, Malgrange B, Moonen G, Rigo JM. Peripheral benzodiazepine receptor (PBR) ligand cytotoxicity unrelated to PBR expression. Biochemical Pharmacology. 69: 819-30. PMID 15710359 DOI: 10.1016/j.bcp.2004.11.029  1
2005 Hans G, Malgrange B, Lallemend F, Crommen J, Wislet-Gendebien S, Belachew S, Robe P, Rogister B, Moonen G, Rigo JM. Beta-carbolines induce apoptosis in cultured cerebellar granule neurons via the mitochondrial pathway. Neuropharmacology. 48: 105-17. PMID 15617732 DOI: 10.1016/j.neuropharm.2004.09.001  1
2004 Belachew S, Gallo V. Synaptic and extrasynaptic neurotransmitter receptors in glial precursors' quest for identity. Glia. 48: 185-96. PMID 15390115 DOI: 10.1002/glia.20077  1
2004 Vautier F, Belachew S, Chittajallu R, Gallo V. Shaker-type potassium channel subunits differentially control oligodendrocyte progenitor proliferation. Glia. 48: 337-45. PMID 15390108 DOI: 10.1002/glia.20088  1
2004 Aguirre AA, Chittajallu R, Belachew S, Gallo V. NG2-expressing cells in the subventricular zone are type C-like cells and contribute to interneuron generation in the postnatal hippocampus. The Journal of Cell Biology. 165: 575-89. PMID 15159421 DOI: 10.1083/jcb.200311141  1
2004 Nguyen L, Malgrange B, Breuskin I, Lallemend F, Hans G, Moonen G, Belachew S, Rigo JM. Striatal PSA-NCAM(+) precursor cells from the newborn rat express functional glycine receptors. Neuroreport. 15: 583-7. PMID 15094457 DOI: 10.1097/00001756-200403220-00003  1
2003 Malgrange B, Knockaert M, Belachew S, Nguyen L, Moonen G, Meijer L, Lefebvre PP. The inhibition of cyclin-dependent kinases induces differentiation of supernumerary hair cells and Deiters' cells in the developing organ of Corti. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 17: 2136-8. PMID 12958157 DOI: 10.1096/fj.03-0035fje  1
2003 Nguyen L, Malgrange B, Rocher V, Hans G, Moonen G, Rigo JM, Belachew S. Chemical inhibitors of cyclin-dependent kinases control proliferation, apoptosis and differentiation of oligodendroglial cells. International Journal of Developmental Neuroscience : the Official Journal of the International Society For Developmental Neuroscience. 21: 321-6. PMID 12927580 DOI: 10.1016/S0736-5748(03)00075-3  1
2003 Nguyen L, Rigo JM, Malgrange B, Moonen G, Belachew S. Untangling the functional potential of PSA-NCAM-expressing cells in CNS development and brain repair strategies. Current Medicinal Chemistry. 10: 2185-96. PMID 12871092 DOI: 10.2174/0929867033456774  1
2003 Nguyen L, Malgrange B, Breuskin I, Bettendorff L, Moonen G, Belachew S, Rigo JM. Autocrine/paracrine activation of the GABA(A) receptor inhibits the proliferation of neurogenic polysialylated neural cell adhesion molecule-positive (PSA-NCAM+) precursor cells from postnatal striatum. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 3278-94. PMID 12716935  1
2003 Belachew S, Chittajallu R, Aguirre AA, Yuan X, Kirby M, Anderson S, Gallo V. Postnatal NG2 proteoglycan-expressing progenitor cells are intrinsically multipotent and generate functional neurons. The Journal of Cell Biology. 161: 169-86. PMID 12682089 DOI: 10.1083/jcb.200210110  1
2002 Yuan X, Chittajallu R, Belachew S, Anderson S, McBain CJ, Gallo V. Expression of the green fluorescent protein in the oligodendrocyte lineage: a transgenic mouse for developmental and physiological studies. Journal of Neuroscience Research. 70: 529-45. PMID 12404507 DOI: 10.1002/jnr.10368  1
2002 Belachew S, Aguirre AA, Wang H, Vautier F, Yuan X, Anderson S, Kirby M, Gallo V. Cyclin-dependent kinase-2 controls oligodendrocyte progenitor cell cycle progression and is downregulated in adult oligodendrocyte progenitors. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 8553-62. PMID 12351729  1
2002 Rigo JM, Hans G, Nguyen L, Rocher V, Belachew S, Malgrange B, Leprince P, Moonen G, Selak I, Matagne A, Klitgaard H. The anti-epileptic drug levetiracetam reverses the inhibition by negative allosteric modulators of neuronal GABA- and glycine-gated currents. British Journal of Pharmacology. 136: 659-72. PMID 12086975 DOI: 10.1038/sj.bjp.0704766  1
2002 Nguyen L, Malgrange B, Belachew S, Rogister B, Rocher V, Moonen G, Rigo JM. Functional glycine receptors are expressed by postnatal nestin-positive neural stem/progenitor cells. The European Journal of Neuroscience. 15: 1299-305. PMID 11994124 DOI: 10.1046/j.1460-9568.2002.01966.x  1
2002 Malgrange B, Belachew S, Thiry M, Nguyen L, Rogister B, Alvarez ML, Rigo JM, Van De Water TR, Moonen G, Lefebvre PP. Proliferative generation of mammalian auditory hair cells in culture. Mechanisms of Development. 112: 79-88. PMID 11850180 DOI: 10.1016/S0925-4773(01)00642-6  1
2001 Belachew S, Yuan X, Gallo V. Unraveling oligodendrocyte origin and function by cell-specific transgenesis. Developmental Neuroscience. 23: 287-98. PMID 11756744 DOI: 10.1159/000048712  1
2001 Nguyen L, Rigo JM, Rocher V, Belachew S, Malgrange B, Rogister B, Leprince P, Moonen G. Neurotransmitters as early signals for central nervous system development. Cell and Tissue Research. 305: 187-202. PMID 11545256 DOI: 10.1007/s004410000343  1
2001 Fumal A, Belachew S, Moonen G, David JL. [Clinical case of the month. Report of a case of antiphospholipid syndrome]. Revue MéDicale De LièGe. 56: 480-3. PMID 11523297  1
2000 Belachew S, Malgrange B, Rigo JM, Rogister B, Leprince P, Hans G, Nguyen L, Moonen G. Glycine triggers an intracellular calcium influx in oligodendrocyte progenitor cells which is mediated by the activation of both the ionotropic glycine receptor and Na+-dependent transporters. The European Journal of Neuroscience. 12: 1924-30. PMID 10886333 DOI: 10.1046/j.1460-9568.2000.00085.x  1
1999 Chanas-Sacré G, Mazy-Servais C, Wattiez R, Pirard S, Rogister B, Patton JG, Belachew S, Malgrange B, Moonen G, Leprince P. Identification of PSF, the polypyrimidine tract-binding protein-associated splicing factor, as a developmentally regulated neuronal protein. Journal of Neuroscience Research. 57: 62-73. PMID 10397636 DOI: 10.1002/(SICI)1097-4547(19990701)57:1<62::AID-JNR7>3.0.CO;2-Y  1
1999 Rogister B, Belachew S, Moonen G. Oligodendrocytes: from development to demyelinated lesion repair. Acta Neurologica Belgica. 99: 32-9. PMID 10218090  1
1999 Belachew S, Rogister B, Rigo JM, Malgrange B, Moonen G. Neurotransmitter-mediated regulation of CNS myelination: a review. Acta Neurologica Belgica. 99: 21-31. PMID 10218089  1
1998 Belachew S, Rogister B, Rigo JM, Malgrange B, Mazy-Servais C, Xhauflaire G, Coucke P, Moonen G. Cultured oligodendrocyte progenitors derived from cerebral cortex express a glycine receptor which is pharmacologically distinct from the neuronal isoform. The European Journal of Neuroscience. 10: 3556-64. PMID 9824468 DOI: 10.1046/j.1460-9568.1998.00369.x  1
1998 Belachew S, Malgrange B, Rigo JM, Rogister B, Coucke P, Mazy-Servais C, Moonen G. Developmental regulation of neuroligand-induced responses in cultured oligodendroglia. Neuroreport. 9: 973-80. PMID 9601652  1
1997 Malgrange B, Rigo JM, Lefebvre PP, Coucke P, Goffin F, Xhauflaire G, Belachew S, Van de Water TR, Moonen G. Diazepam-insensitive GABAA receptors on postnatal spiral ganglion neurones in culture. Neuroreport. 8: 591-6. PMID 9106729  1
1996 Malgrange B, Rigo JM, Coucke P, Belachew S, Rogister B, Moonen G. Beta-carbolines induce apoptotic death of cerebellar granule neurones in culture. Neuroreport. 7: 3041-5. PMID 9116236  1
1996 Rigo JM, Belachew S, Coucke P, Leprince P, Malgrange B, Rogister B, Moonen G. Astroglia-released factor with negative allosteric modulatory properties at the GABA A receptor. Biochemical Pharmacology. 52: 465-73. PMID 8687501 DOI: 10.1016/0006-2952(96)00249-3  1
1996 Malgrange B, Rigo JM, Coucke P, Belachew S, Rogister B, Moonen G. Can a negative allosteric modulation of GABA(A) receptor kill neurons? Neuroreport. 7: R1.  1
1994 Rigo JM, Belachew S, Lefebvre PP, Leprince P, Malgrange B, Rogister B, Kettenmann H, Moonen G. Astroglia-released factor shows similar effects as benzodiazepine inverse agonists. Journal of Neuroscience Research. 39: 364-76. PMID 7884817 DOI: 10.1002/jnr.490390403  1
Show low-probability matches.